MX2019010370A - Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. - Google Patents

Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.

Info

Publication number
MX2019010370A
MX2019010370A MX2019010370A MX2019010370A MX2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A MX 2019010370 A MX2019010370 A MX 2019010370A
Authority
MX
Mexico
Prior art keywords
purified
compositions
cannabinoids
terpenes
compositions comprise
Prior art date
Application number
MX2019010370A
Other languages
English (en)
Spanish (es)
Inventor
Michael Cooper Jonathan
Levy Kurt
Reed Martin Jonathan
Geoffrey Reid Brian
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/616,874 external-priority patent/US20170266153A1/en
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of MX2019010370A publication Critical patent/MX2019010370A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
MX2019010370A 2017-03-01 2018-03-01 Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados. MX2019010370A (es)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US201762465688P 2017-03-01 2017-03-01
US201762469415P 2017-03-09 2017-03-09
US201762475153P 2017-03-22 2017-03-22
US201762477990P 2017-03-28 2017-03-28
US201762489360P 2017-04-24 2017-04-24
US201762490465P 2017-04-26 2017-04-26
US201762490567P 2017-04-26 2017-04-26
US201762491175P 2017-04-27 2017-04-27
US201762491160P 2017-04-27 2017-04-27
US201762491980P 2017-04-28 2017-04-28
US201762491899P 2017-04-28 2017-04-28
US201762509651P 2017-05-22 2017-05-22
US201762510229P 2017-05-23 2017-05-23
US201762510660P 2017-05-24 2017-05-24
US201762510672P 2017-05-24 2017-05-24
US201762511218P 2017-05-25 2017-05-25
US15/616,874 US20170266153A1 (en) 2015-02-27 2017-06-07 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
PCT/US2018/020440 WO2018160827A1 (fr) 2017-03-01 2018-03-01 Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés

Publications (1)

Publication Number Publication Date
MX2019010370A true MX2019010370A (es) 2019-10-22

Family

ID=63370542

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019010370A MX2019010370A (es) 2017-03-01 2018-03-01 Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.

Country Status (10)

Country Link
EP (1) EP3589129A4 (fr)
CN (1) CN110582206A (fr)
AU (1) AU2018227544A1 (fr)
BR (1) BR112019018088A2 (fr)
CA (1) CA3054690A1 (fr)
CO (1) CO2019009413A2 (fr)
IL (1) IL268929A (fr)
MX (1) MX2019010370A (fr)
PE (1) PE20200383A1 (fr)
WO (1) WO2018160827A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10737198B2 (en) 2018-01-23 2020-08-11 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
IL266151A (en) * 2019-04-18 2019-07-31 Kanabo Res Ltd Dilute for the cannabinoid preparations
WO2021012044A1 (fr) 2019-07-22 2021-01-28 Canopy Growth Corporation Cristallisation continue de cannabinoïdes dans un réacteur à cuve agitée
KR20220106158A (ko) * 2019-11-26 2022-07-28 라이코드 리미티드 칸나비노이드 및 라이코펜 항염증 상승작용적 조합물
EP4142929A4 (fr) * 2020-04-29 2024-02-21 Ligar Lp Polymères à empreinte et procédés pour leur utilisation
CA3152633A1 (fr) * 2020-07-27 2022-02-03 Canopy Growth Corporation Procedes de synthese de cannabielsoin et d'analogues de ceux-ci
WO2022165165A1 (fr) * 2021-01-29 2022-08-04 The Johns Hopkins University Effets de limonène sur l'anxiété induite par tétrahydrocannabinol (thc)
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
WO2023245185A1 (fr) * 2022-06-17 2023-12-21 New Growth Brands, Inc. Compositions comprenant des cannabinoïdes et leurs procédés de préparation et d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
CA2931039C (fr) * 2013-11-20 2022-07-12 Mary Lynch Compositions et methodes de traitement de l'inflammation oculaire et de la douleur
BR112017018316A2 (pt) * 2015-02-27 2018-04-17 Ebbu Llc composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral

Also Published As

Publication number Publication date
IL268929A (en) 2019-10-31
EP3589129A4 (fr) 2020-11-25
AU2018227544A1 (en) 2019-08-29
CN110582206A (zh) 2019-12-17
CA3054690A1 (fr) 2018-09-07
WO2018160827A1 (fr) 2018-09-07
BR112019018088A2 (pt) 2020-03-24
CO2019009413A2 (es) 2019-09-09
PE20200383A1 (es) 2020-02-24
EP3589129A1 (fr) 2020-01-08

Similar Documents

Publication Publication Date Title
MX2019010370A (es) Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados.
MX2017010872A (es) Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
EP3687527A4 (fr) Compositions comprenant du cannabidiol, du tétrahydrocannabinol, des terpènes et des flavonoïdes et leur utilisation dans le traitement de l'insomnie
JOP20170055B1 (ar) تركيبة شراب تحتوي على اليولوز وطعام يحتوي على التركيبة
WO2017083363A9 (fr) Conservateurs naturels et agents antimicrobiens, comprenant des compositions associées
EP3758671A4 (fr) 1,2-alcanediols naturels, compositions comportant des 1,2-alcanediols naturels et leurs procédés de préparation
WO2021217004A3 (fr) Procédés et compositions pour le traitement d'une inflammation associée à un virus
WO2019020602A3 (fr) Luminophore et composition
SG10201808151RA (en) Cortistatin analogues and syntheses and uses thereof
MY185981A (en) Glycoside compositions
CL2008001755A1 (es) Metodo para reducir efectos de deterioro asociado con pesticidas, fertilizantes o una combinacion de los mismos en una planta que comprende el tratamiento con al menos un compuesto derivado de ciclopropeno.
MX2017012803A (es) Produccion de poliuretanos de bajas emisiones.
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
UY38284A (es) Composiciones y métodos para agonizar el receptor cb2
GB201901099D0 (en) Methods, uses and compositions
MX2019013250A (es) 2,3,7-trimetiloct-6-enil acetato y 3,7-dimetil-2-metilen-oct-6-eni l acetato y derivados de estos y su uso como sustancias quimicas aromaticas.
GB2543723A (en) Polyphenol compositions
MX2017013278A (es) Odorante osmanthus.
CO2017004809A2 (es) Composiciones de triptamidas
IL270833B (en) Synergistic preparations containing (r)-dimiracetam (1) and (s)-dimidacetam (2) in a non-sequential ratio
MX2020001992A (es) Peliculas acrilicas quebradizas y etiquetas para la prevencion de la falsificacion que comprenden las mismas.
MX2019009200A (es) Composiciones y métodos para inhibir el reticulón 4.
MX2020010424A (es) Comprimido o composicion que contiene n-acil etanolamina y cannabinoides.
MX2018007398A (es) Composicion para mejorar la sensacion bucal.
MX2022000370A (es) Composicion repelente de artropodos.